These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29752583)

  • 21. Quality of Life Outcomes in a Pediatric Thalassemia Population in Egypt.
    Adam S; Afifi H; Thomas M; Magdy P; El-Kamah G
    Hemoglobin; 2017 Jan; 41(1):16-20. PubMed ID: 28440111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life among beta-thalassemic major children presenting at Federal Government Hospital Islamabad, Pakistan.
    Bukhari GMJ
    J Pak Med Assoc; 2022 Nov; 72(11):2241-2244. PubMed ID: 37013295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of educational programme regarding chelation therapy on the quality of life for B-thalassemia major children.
    Abu Samra O; Auda W; Kamhawy H; Al-Tonbary Y
    Hematology; 2015 Jun; 20(5):297-303. PubMed ID: 25181014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of Life of Pakistani Children with β-Thalassemia Major.
    Yasmeen H; Hasnain S
    Hemoglobin; 2018; 42(5-6):320-325. PubMed ID: 30700180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive patient care improves quality of life in transfusion dependent patients with β-thalassemia.
    Ali SS; Tarawah AM; Al-Hawsawi ZM; Zolaly MA; Turkustani W
    Saudi Med J; 2015 May; 36(5):575-9. PubMed ID: 25935178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of early start of iron chelation therapy with deferiprone in young children newly diagnosed with transfusion-dependent thalassemia: A randomized controlled trial.
    Elalfy MS; Adly A; Awad H; Tarif Salam M; Berdoukas V; Tricta F
    Am J Hematol; 2018 Feb; 93(2):262-268. PubMed ID: 29119631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cultural preferences and limited public resources influence the spectrum of thalassemia in Egypt.
    Adly AA; Ebeid FS
    J Pediatr Hematol Oncol; 2015 May; 37(4):281-4. PubMed ID: 25811748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post Splenectomy Outcome in β-Thalassemia.
    Merchant RH; Shah AR; Ahmad J; Karnik A; Rai N
    Indian J Pediatr; 2015 Dec; 82(12):1097-100. PubMed ID: 26099360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pilot study on the "quality of life" as reflected by psychosocial adjustment of children with thalassemia major undergoing iron-chelating treatment in western Taiwan.
    Kuo HT; Tsai MY; Peng CT; Wu KH
    Hemoglobin; 2006; 30(2):291-9. PubMed ID: 16798654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality Matters - Hematopoietic Stem Cell Transplantation versus Transfusion and Chelation in Thalassemia Major.
    Patel S; Swaminathan VV; Mythili VS; Venkatadesikalu MS; Sivasankaran M; Jayaraman D; Balasubramaniam R; Uppuluri R; Raj R
    Indian Pediatr; 2018 Dec; 55(12):1056-1058. PubMed ID: 30745477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical utility of health-related quality of life assessment in pediatric cardiology outpatient practice.
    Uzark K; King E; Spicer R; Beekman R; Kimball T; Varni JW
    Congenit Heart Dis; 2013; 8(3):211-8. PubMed ID: 22967147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of SCOPE Program on Health-Related Quality of Life and Health Status of Children With Thalassemia: A Quasi-Experimental Study.
    K K; A P; Sikandar BJ
    J Pediatr Hematol Oncol Nurs; 2024; 41(3):199-211. PubMed ID: 38646835
    [No Abstract]   [Full Text] [Related]  

  • 34. Thalassemia Minor and Major: Current Management.
    Choudhry VP
    Indian J Pediatr; 2017 Aug; 84(8):607-611. PubMed ID: 28435994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of quality of life in children with nephrotic syndrome at a teaching hospital in South India.
    Agrawal S; Krishnamurthy S; Naik BN
    Saudi J Kidney Dis Transpl; 2017; 28(3):593-598. PubMed ID: 28540898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of desferrioxamine, deferiprone and in combination on iron chelation in thalassemic children.
    Gomber S; Saxena R; Madan N
    Indian Pediatr; 2004 Jan; 41(1):21-7. PubMed ID: 14767084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of patients with major beta thalassemia in a paediatric department in the south of Tunisia: About 26 cases].
    Maaloul I; Laaroussi O; Jedidi I; Sfaihi L; Kmiha S; Kamoun T; Aloulou H; Hachicha M
    Transfus Clin Biol; 2018 Feb; 25(1):14-18. PubMed ID: 29199112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of secondary sex characteristics in multitransfused thalassemic children.
    George A; Bhaduri A; Choudhry VP
    Indian J Pediatr; 1997; 64(6):855-9. PubMed ID: 10771930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing agreement between child self-report and parent proxy-reports on the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core scales.
    Cremeens J; Eiser C; Blades M
    Health Qual Life Outcomes; 2006 Aug; 4():58. PubMed ID: 16942613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinico-biological and immunohaematological profile of patients with β-thalassemia in Tunisia: about 26 cases].
    Romdhane H; Amara H; Abdelkefi S; Souyeh N; Chakroun T; Jarrey I; Bouslama M; Belhedi S; Houissa B; Boughammoura L; Jemni Yacoub S
    Transfus Clin Biol; 2014 Dec; 21(6):309-13. PubMed ID: 25458984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.